Founder, Blamey Saunders · angel in 1 deal
Every published round Dr Dr Peter Blamey took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Laronix | Seed | Aug 2023 | $2m | Participant | Startup Daily, SmartCompany (Mon 27 Jul 2026), Forbes Australia, SmartCompany (Fri 25 Aug 2023), Wholesale Investor |
Companies Dr Dr Peter Blamey has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Laronix | Aug 2023, Seed | 1 | 0 |
Fund closes reported for Dr Dr Peter Blamey, as distinct from the investments it has made.
Companies Dr Dr Peter Blamey has backed that another company then bought. An exit for the holding, not a deal Dr Dr Peter Blamey did.
Stories naming Dr Dr Peter Blamey. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Queensland medtech Laronix has built AI that recreates patients' own voices from brief recordings; the profile recalls its 2023 seed round, earlier federal grants and a 2025 non-dilutive award.
Also Startup Daily
Weekly roundup covering fresh raises by four Australian startups: Ignition's banking facility, HEO Robotics' Series A, Laronix's seed round and Haast's pre-seed, plus a past ACT grant.
Also Australian FinTech·SmartCompany·SmartCompany·Startup Daily·Forbes Australia·Wholesale Investor